This inventor holds 6 USPTO granted patents, plus 7 CIPO patents and 5 EPO patents. Top assignees: Samyang Corporation, Samyang Biopharmaceuticals Corporation, Samyang Holdings Corporation. Active years: 2010-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2010-2026
Title: Bong-Oh Kim: Innovator in Pharmaceutical Composition and Drug Delivery Systems
Introduction
Bong-Oh Kim is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceutical compositions and drug delivery systems. With a total of 6 patents, his work focuses on innovative methods to enhance drug delivery, particularly for anionic drugs.
Latest Patents
Among his latest patents, Bong-Oh Kim has developed a pharmaceutical composition for anionic drug delivery. This composition includes an anionic drug as an active ingredient, a cationic compound, an amphiphilic block copolymer, and a polylactate. The anionic drug forms a complex with the cationic lipid, which is then encapsulated within a micelle structure formed by the amphiphilic block copolymer and the polylactate. Another notable patent involves pH responsive biodegradable polylactic acid derivatives that form polymeric micelles. These derivatives are capable of encapsulating poorly water-soluble drugs, making them a versatile option for drug delivery systems.
Career Highlights
Bong-Oh Kim has worked with notable companies such as Samyang Corporation and Samyang Biopharmaceuticals Corporation. His experience in these organizations has allowed him to develop and refine his innovative approaches to drug delivery.
Collaborations
Throughout his career, Bong-Oh Kim has collaborated with esteemed colleagues, including Min-Hyo Seo and Myung-Seob Shim. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Bong-Oh Kim's contributions to pharmaceutical compositions and drug delivery systems highlight his innovative spirit and dedication to improving healthcare solutions. His patents reflect a commitment to addressing the challenges associated with drug delivery, particularly for anionic drugs.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile